Archives

Targeting VEGF in AMD
Anti-VEGF treatments have revolutionalized AMD therapy.

by Rishi P. Singh, MD; and Peter K. Kaiser, MD
New Molecular Targets in the Treatment of Ocular Neovascular Diseases
The role of platelet-derived growth factor-B for inhibiting growth of aberrant vessels.

by David T. Shima, PhD, and Anthony P. Adamis, MD
5 Questions with Johanna M. Seddon, MD, ScM
Dr. Seddon is the director of epidemiology at Massachusetts Eye and Ear infirmary, and surgeon in ophthalmology, associate professor of ophthalmology at Harvard Medical School.

by Johanna M. Seddon, MD, ScM
Welcome to the Second Issue of Retina Today
We hope you enjoyed the first issue of Retina Today and are ready to dive into the second edition.
Corneal Dryness Affects OCT Scan Quality
The drying effects were relatively long lasting, therefore imaging studies should be conducted before automated perimetry.

by CONNI BERGMANN KOURY, EDITOR-IN-CHIEF

Molecular Biology of Diabetic Retinopathy: How to Best Preseve Vision in these Patients
Jointly sponsored by The Dulaney Foundation and Retina Today. Release Date: July 2006. Expiration Date: July 31, 2007. This continuing medical education activity is supported by an educational grant from Eli Lilly and Company.

By Lloyd Paul Aiello, MD, PhD
Clinical Trial Update: Retinal Surgery
Trial: Full Thickness Macular Hole (FTMH) and Internal Limiting Membrane (ILM) Peeling Study
Clinical Trial Update: Macular Diseases
Clinical Trial Update: AMD
Trial: A Phase 4, Open Label, Multi-Center, Study of Maintenance Intravitreous Injections of Pegaptanib Sodium (Macugen) Given Every 6 Weeks for 48 Weeks in Subjects With Subfoveal Neovascular Age-related Macular Degeneration (AMD) Initially Treated With a Modality Resulting in Maculopathy Improvement
Highlights from the Cannes Retina Festival: 24th Annual Meeting of ASRS & 6th Annual Meeting of EVRS
Jointly sponsored by The Dulaney Foundation and Retina Today Release Date: November 2006. Expiration Date: November 30, 2007. This continuing medical education activity is supported by an educational grant from Eli Lilly and Company.

By RISHI P. SINGH, MD